Trials / Recruiting
RecruitingNCT03859050
Alveolar Macrophage Programming Following Endotoxin Exposure
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (estimated)
- Sponsor
- National Jewish Health · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The histologic hallmarks of lung inflammation include accumulation of inflammatory cells in the airspaces and interstitium, injury to alveolar epithelial and endothelial cells, loss of epithelial-capillary integrity and accumulation of edema fluid in the interstitium and airspaces. Accordingly, for alveolar repair to occur inflammation must be halted, debris and inflammatory cells removed, injured tissue cells replaced, and capillary barrier function re-established. Macrophages are key players in all of these. Here the investigators hypothesize that resident alveolar macrophages and recruited macrophages serve completely different functions, acting independently (i.e. division of labor) yet cooperatively (synergism).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | bronchoscopy with intrabronchial administration of lipopolysaccharide | The PI will administer intrabronchial LPS into the lungs of healthy volunteers and then obtaining macrophages by bronchoalveolar lavage (BAL) 24, 48, 72, 96, or 120 hours later. |
Timeline
- Start date
- 2019-03-18
- Primary completion
- 2029-07-01
- Completion
- 2032-07-01
- First posted
- 2019-03-01
- Last updated
- 2025-05-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03859050. Inclusion in this directory is not an endorsement.